Thanks Neuro, I thought that maybe Cortex was trying with the in-licensing push to protect themselves from a negative FDA ruling just in case they have to raise money in that timeframe.
But as you listed in #msg-17406307, there are actually several financial options Cortex would have available if the FDA decision is bad.
Since we know it's definitely coming, the in-licensing is going to be an interesting topic of speculation ahead of time, and of heavy duty discussion (and likely strong opinions) once we see what's behind the curtain... Aiming4.